This is a preprint.
A Strategic Blend of Stabilizing Polymers to Control Particle Surface Charge for Enhanced Mucus Transport and Cell Binding
- PMID: 39345382
- PMCID: PMC11429750
- DOI: 10.1101/2024.09.17.613453
A Strategic Blend of Stabilizing Polymers to Control Particle Surface Charge for Enhanced Mucus Transport and Cell Binding
Abstract
Mucus layers, viscoelastic gels abundant in anionic mucin glycoproteins, obstruct therapeutic delivery across all mucosal surfaces. We found that strongly positively charged nanoparticles (NPs) rapidly adsorb a mucin protein corona in mucus, impeding cell binding and uptake. To overcome this, we developed mucus-evading, cell-adhesive (MECS) NPs with variable surface charge using Flash NanoPrecipitation, by blending a neutral poly(ethylene glycol) (PEG) corona for mucus transport with a small amount, 5 wt%, of polycationic dimethylaminoethyl methacrylate (PDMAEMA) for increased cell targeting. In vitro experiments confirmed rapid mucus penetration and binding to epithelial cells by MECS NPs, suggesting a breakthrough in mucosal drug delivery.
Conflict of interest statement
Competing interests CAS, BS, BKW, KR and RKP are co-inventors on a patent disclosure MBHB 24-0253-US-PRO.
Figures




Similar articles
-
Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.ACS Nano. 2015 Sep 22;9(9):9217-27. doi: 10.1021/acsnano.5b03876. Epub 2015 Aug 31. ACS Nano. 2015. PMID: 26301576 Free PMC article.
-
Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.ACS Appl Mater Interfaces. 2018 Mar 28;10(12):9916-9928. doi: 10.1021/acsami.7b16524. Epub 2018 Mar 15. ACS Appl Mater Interfaces. 2018. PMID: 29504398
-
On the synthesis of mucus permeating nanocarriers.Eur J Pharm Biopharm. 2015 Nov;97(Pt A):239-49. doi: 10.1016/j.ejpb.2015.01.021. Epub 2015 Feb 3. Eur J Pharm Biopharm. 2015. PMID: 25661586
-
Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier.ACS Biomater Sci Eng. 2022 Apr 11;8(4):1396-1426. doi: 10.1021/acsbiomaterials.2c00047. Epub 2022 Mar 16. ACS Biomater Sci Eng. 2022. PMID: 35294187 Review.
-
PEGylation for enhancing nanoparticle diffusion in mucus.Adv Drug Deliv Rev. 2018 Jan 15;124:125-139. doi: 10.1016/j.addr.2017.08.010. Epub 2017 Sep 4. Adv Drug Deliv Rev. 2018. PMID: 28882703 Review.
References
-
- Vargason A. M., Anselmo A. C. & Mitragotri S. The evolution of commercial drug delivery technologies. Nat. Biomed. Eng. 5, 951–967 (2021). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources